Benjamin Jackson, a fifth year student in the Tri-I MD-PhD Program, has been awarded an F30 research grant by the National Institutes of Health (NIH). This award will support Mr. Jackson's research in the Finley Lab at Gerstner Sloan Kettering Graduate School at MSK, where he is currently working toward his PhD.
In particular, this award is in support of Ben's project Metabolic control of exit from naïve pluripotency, which he contextualizes and describes as:
"Metabolic activity is dynamically regulated across cell states in development and disease and can contribute to the establishment of cell fate. The goal of my thesis research is to identify the mechanisms by which metabolic pathways support the exit from naïve pluripotency in mouse embryonic stem cells. These studies will enhance our understanding of how metabolism enables successful execution of developmental programs."